Health Inc. : Shots - Health NewsAs spending on care rises, the business of health keeps getting more important. We feature news on and analysis of drugmakers, health insurers, hospitals, doctors and others in the business of providing health care.
Medical errors are a leading cause of death and injuries in U.S. hospitals, according to the Institute of Medicine.
VILevi/Getty Images/iStockphoto
hide caption
Carl Goulden, of Littlestown Pa., developed hepatitis B 10 years ago. Soon his health insurance premiums soared beyond a price he and his wife could afford.
Elana Gordon/WHYY
hide caption
An EpiPen Jr. epinephrine auto-injector. Some EpiPens have been recalled from the U.S. market over concerns that they could fail to activate when people try to use them.
Chris Ratcliffe/Bloomberg via Getty Images
hide caption
Gilead Sciences Inc. makes the two leading drugs that can quickly cure hepatitis C infections. But most patients can't afford the expensive drugs, and states restrict their use among Medicaid patients.
David Paul Morris/Bloomberg via Getty Images
hide caption
Rep. Lloyd Doggett, D-Texas, is promoting a campaign to get the National Institutes of Health to exercise the patent rights it already owns in regards to certain drugs to bring down their price.
Bill Clark/CQ-Roll Call, Inc.
hide caption
Advocates of paying a family doctor a flat monthly fee for office visits and some lab work say it saves patients money when coupled with a high-deductible insurance plan.
Ridofranz/Getty Images/iStockphoto
hide caption
A health savings account works much like a personal savings account — with a difference. Any money in it that we use to pay for certain medical expenses isn't taxed.
Oivind Hovland/Ikon Images/Getty Images
hide caption
Senate Judiciary Committee Chairman Chuck Grassley, R-Iowa, is looking into how the Orphan Drug Act may be affecting a wide range of drug prices.
Andrew Harnik/AP
hide caption